# EFfects of Y-6 SUblingual Tablets foR PaTients With AcUte Ischemic StRokE (FUTURE)

> **NCT06138834** · PHASE2 · UNKNOWN · sponsor: **Beijing Tiantan Hospital** · enrollment: 300 (estimated)

## Conditions studied

- Acute Ischemic Stroke
- Large Vessel Occlusion
- Reperfusion

## Interventions

- **DRUG:** Low-dose Y-6 sublingual tablets
- **DRUG:** High-dose Y-6 sublingual tablets
- **DRUG:** Low-dose Cilostazol
- **DRUG:** High-dose Cilostazol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06138834
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-11
- **Primary completion:** 2024-11
- **Final completion:** 2025-01
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2023-11-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06138834

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06138834, "EFfects of Y-6 SUblingual Tablets foR PaTients With AcUte Ischemic StRokE (FUTURE)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06138834. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*